APPLICATION
ANDA213663
TYPE
ANDA
ORIGINAL APPROVAL
2020-09-24
LATEST ACTION
2020-09-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDEOver-the-counter
DIPHENHYDRAMINE HYDROCHLORIDE 25MG, NAPROXEN SODIUM 220MG · TABLET · ORAL
Approval history
2020-09-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.